Postprandial Hyperglycemia and Cardiovascular Disease Is the HEART2D study the answer?

被引：27

作者：

Ceriello, Antonio ^{[1
]}

机构：

[1] Univ Warwick, Warwick Med Sch, Univ Hosp Coven & Warwickshire, Ctr Excellence Diabet & Endocrinol, Coventry CV4 7AL, W Midlands, England

来源：

DIABETES CARE | 2009年 / 32卷 / 03期

关键词：

IMPAIRED GLUCOSE-TOLERANCE; BLOOD-GLUCOSE; TYPE-2; OUTCOMES; COMPLICATIONS; MANAGEMENT; GUIDELINE; MORTALITY; GLYCEMIA;

D O I：

10.2337/dc08-2209

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：521 / 522

页数：2

共 17 条

[1] Prevention of diabetes and cardiovascular' disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial [J].

Califf, Robert M. ;

Boolell, Mitradev ;

Haffner, Steven M. ;

Bethel, M. Angelyn ;

McMurray, John ;

Duggal, Anil ;

Holman, Rury R. .

AMERICAN HEART JOURNAL, 2008, 156 (04) :623-632

[2] Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: Lessons from the San Luigi Gonzaga Diabetes Study [J].

Cavalot, F ;

Petrelli, A ;

Traversa, M ;

Bonomo, K ;

Fiora, E ;

Conti, M ;

Anfossi, G ;

Costa, G ;

Trovati, M .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :813-819

[3] International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations [J].

Ceriello, A. ;

Colagiuri, S. .

DIABETIC MEDICINE, 2008, 25 (10) :1151-1156

[4] Postprandial glucose regulation and diabetic complications [J].

Ceriello, A ;

Hanefeld, M ;

Leiter, L ;

Monnier, L ;

Moses, A ;

Owens, D ;

Tajima, N ;

Tuomilehto, J .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (19) :2090-2095

[5] Postprandial hyperglycemia and diabetes complications - Is it time to treat? [J].

Ceriello, A .

DIABETES, 2005, 54 (01) :1-7

[6] Guideline for management of postmeal glucose [J].

Ceriello, Antonio ;

Colagiuri, Stephen ;

Gerich, John ;

Tuomilehto, Jaakko .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (04) :S17-S33

[7] Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial [J].

Chiasson, JL ;

Josse, RG ;

Gomis, R ;

Hanefeld, M ;

Karasik, A ;

Laakso, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (04) :486-494

[8] Effect of a multifactorial intervention on mortality in type 2 diabetes [J].

Gaede, Peter ;

Lund-Andersen, Henrik ;

Parving, Hans-Henrik ;

Pedersen, Oluf .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) :580-591

[9]

Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743

[10] Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies [J].

Hanefeld, M ;

Cagatay, M ;

Petrowitsch, T ;

Neuser, D ;

Petzinna, D ;

Rupp, M .

EUROPEAN HEART JOURNAL, 2004, 25 (01) :10-16

← 1 2 →